Evidence suggests new CEO Peter Arduini will use innovation and cost efficiencies to drive EPS growth.
He is a veteran CEO who led Integra LifeSciences from 2012–2021, where he doubled sales and tripled adjusted net income through organic growth, cost efficiencies, and M&A.
Sources were unanimously positive, citing Arduini’s operational abilities, strategic insights and track record, which includes the transformation of Integra from essentially a holding company into an integrated, high functioning enterprise.
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.